Anxiety
Conditions
Interventions
Experimental group Group A- 82 pregnants.
Using Flower Essences from England.
The stock essence will be used, Five-Flower Formula, imported from England for Healing
Flower Essences. The formula cons
Other
Sponsors
Escola Paulista de Enfermagem-Universidade Federal de São Paulo
Secretária Municipal de Saúde de São Paulo.
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Do not have obstetric pathologies; Being in the active phase of labor, diagnosed on admission by the treatment team minimum 3 cm cervical dilatation and maximum of 8 cm; term gestational age between 37 and 42 completed weeks calculated by last menstrual period and or the result of early ultrasound, that is held up to 20 weeks; Minimum age of 18 years; pregnancy with a single fetus alive.
Exclusion criteria
Exclusion criteria: Smokers who has smoked less than two hours after nicotine influence on catecholamine secretion; Bearers of mental disorders, documented in the medical record, which would influence his decision and autonomy; They reported having ingested caffeine in the last 10 hours, thus altering the secretion of catecholamines; Users of psychoactive drugs, which influence his decision and autonomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected denouement: Reducing anxiety of pregnant women submitted to treatment with floral therapy. The evaluation of the intensity of anxiety be performed before treatment and thirty minutes after administration of the last dose therapy, is the experimental group or the control group using numeric scale ranging from 0 to 10, 0 being the absence of symptom and 10 the worst possible intensity, vital parameters, blood pressure, pulse, breathing and samples of biological material saliva for dosage of hormones cortisol, beta-endorphin, epinephrine and norepinephrine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected denouement: Pain reduction of pregnant women submitted to treatment with floral therapy. The evaluation of pain intensity will be performed prior to therapy and thirty minutes after administration of the last dose therapy, is the experimental group or the control group using numeric scale ranging from 0 to 10, 0 being the absence of symptom and 10 the worst possible intensity, vital parameters, blood pressure, pulse and breathing and samples of biological material saliva for dosage of hormones cortisol, beta-endorphin, epinephrine and norepinephrine | — |
Countries
Brazil
Contacts
Public ContactSonia Godinho de Lara
Escola Paulista de Enfermagem-Universidade Federal de São Paulo
Outcome results
None listed